# Enoxaparin Sodium

NDC: 63323-655
Generic name: Enoxaparin Sodium
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20190501

FDA application: ANDA078990

## Active ingredients

- ENOXAPARIN SODIUM: 120 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-655"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-655
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a694bbc3-4eb0-4c1e-b4ff-b8abc3e5148e